Impact of radiation dose to the immune cells in unresectable or stage III non-small cell lung cancer in the durvalumab era.
McCall NS, McGinnis HS, Janopaul-Naylor JR, Kesarwala AH, Tian S, Stokes WA, Shelton JW, Steuer CE, Carlisle JW, Leal T, Ramalingam SS, Bradley JD, Higgins KA.
McCall NS, et al. Among authors: mcginnis hs.
Radiother Oncol. 2022 Sep;174:133-140. doi: 10.1016/j.radonc.2022.07.015. Epub 2022 Jul 20.
Radiother Oncol. 2022.
PMID: 35870727